Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract
Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract
JASIMA
Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract
Statut
Status :
Terminé
Type d'étude
Phase II
Age Min.
18
Ans
Age Max.
-
Genre
Tous
Aire thérapeutique :
Oncologie
Maladie :
Carcinome urothélial
Traitement :
Vinflunine (Javlor®)
Phase :
Phase II
Date de début de l'étude :
30 Juin 2011
End date :
14 Février 2015
Identifiant de l'essai :
L00070 IN 214 P1
Identifiant EudraCT/CTIS :
2011-000272-34
Envoyer par email